HUP0303174A3 - Malic acid addition salts of terbinafine, process for their preparation and pharmaceutical compositions containing them - Google Patents

Malic acid addition salts of terbinafine, process for their preparation and pharmaceutical compositions containing them

Info

Publication number
HUP0303174A3
HUP0303174A3 HU0303174A HUP0303174A HUP0303174A3 HU P0303174 A3 HUP0303174 A3 HU P0303174A3 HU 0303174 A HU0303174 A HU 0303174A HU P0303174 A HUP0303174 A HU P0303174A HU P0303174 A3 HUP0303174 A3 HU P0303174A3
Authority
HU
Hungary
Prior art keywords
terbinafine
preparation
pharmaceutical compositions
acid addition
addition salts
Prior art date
Application number
HU0303174A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HUP0303174A2 publication Critical patent/HUP0303174A2/hu
Publication of HUP0303174A3 publication Critical patent/HUP0303174A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/30Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by two rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Seasonings (AREA)
HU0303174A 2001-02-07 2002-02-06 Malic acid addition salts of terbinafine, process for their preparation and pharmaceutical compositions containing them HUP0303174A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0103046.9A GB0103046D0 (en) 2001-02-07 2001-02-07 Organic Compounds
PCT/EP2002/001249 WO2002070455A1 (en) 2001-02-07 2002-02-06 Malic acid addition salts of terbinafine

Publications (2)

Publication Number Publication Date
HUP0303174A2 HUP0303174A2 (hu) 2003-12-29
HUP0303174A3 true HUP0303174A3 (en) 2008-03-28

Family

ID=9908301

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303174A HUP0303174A3 (en) 2001-02-07 2002-02-06 Malic acid addition salts of terbinafine, process for their preparation and pharmaceutical compositions containing them

Country Status (27)

Country Link
US (2) US20040147603A1 (enExample)
EP (1) EP1370513B1 (enExample)
JP (1) JP4078206B2 (enExample)
KR (2) KR20080041756A (enExample)
CN (1) CN1216034C (enExample)
AT (1) ATE294154T1 (enExample)
AU (1) AU2002238534C1 (enExample)
BR (1) BR0207077A (enExample)
CA (1) CA2437592A1 (enExample)
CZ (1) CZ20032132A3 (enExample)
DE (1) DE60203890T2 (enExample)
DK (1) DK1370513T3 (enExample)
EC (1) ECSP034713A (enExample)
ES (1) ES2240698T3 (enExample)
GB (1) GB0103046D0 (enExample)
HU (1) HUP0303174A3 (enExample)
IL (2) IL157241A0 (enExample)
MX (1) MXPA03007072A (enExample)
NO (1) NO20033473L (enExample)
NZ (1) NZ527300A (enExample)
PL (1) PL204812B1 (enExample)
PT (1) PT1370513E (enExample)
RU (1) RU2289570C2 (enExample)
SI (1) SI1370513T1 (enExample)
SK (1) SK9992003A3 (enExample)
WO (1) WO2002070455A1 (enExample)
ZA (1) ZA200306029B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003244633A1 (en) * 2002-07-02 2004-01-23 Novartis Ag Methods for the treatment of sinusitis
GB0503942D0 (en) * 2005-02-25 2005-04-06 Novartis Ag Purification process
RU2286144C2 (ru) * 2004-12-02 2006-10-27 Государственное научное учреждение Институт экспериментальной ветеринарии Сибири и Дальнего Востока Сибирского отделения Россельхозакадемии (ГНУ ИЭВСиДВ СО РАСХН) Способ лечения микроспории кошек
WO2007104474A1 (en) * 2006-03-10 2007-09-20 Novartis Ag Antifungal compositions comprising (1) a salt of terbinafine with malic acid and (2) malic acid
CA2653782A1 (en) * 2006-06-14 2007-12-21 Dr. Reddy's Laboratories Limited Topical compositions
RU2350343C1 (ru) * 2007-08-13 2009-03-27 Государственное научное учреждение Институт экспериментальной ветеринарии Сибири и Дальнего Востока Сибирского отделения Россельхозакадемии (ГНУ ИЭВС и ДВ СО Россельхозакадемии) Способ лечения микроспории кошек
DK2387563T4 (da) 2009-01-16 2022-07-18 Exelixis Inc Malatsalt af n-(4-{ [ 6, 7-bis(methyloxy)quinolin-4-yl]oxy}phenyl-n'-(4-fluorphenyl)cyclopropan-1,1-dicarboxamid, og krystallinske former deraf til behandling af cancer
CN106106449A (zh) * 2016-06-21 2016-11-16 广西中烟工业有限责任公司 特比萘芬制剂及其在提高烟叶角鲨烯含量中的应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507755A (en) * 1967-10-17 1970-04-21 Bayer Ag Process for the purification of acrylonitrile by distillation with side stream withdrawal and decantation
US4276125A (en) 1979-02-02 1981-06-30 Asahi Kasei Kogyo Kabushiki Kaisha Process for purification of crude olefinically unsaturated nitrile and condenser useful for same process
US4269667A (en) 1979-08-02 1981-05-26 Standard Oil Company Acrylonitrile purification by extractive distillation
EP0024587B1 (en) * 1979-08-22 1984-11-14 Sandoz Ag Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
KR850001603B1 (ko) 1980-12-03 1985-10-24 아사히 가세이 고오교오 가부시기가이샤 불포화 니트릴의 제조법
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
NZ227042A (en) * 1987-11-27 1991-05-28 Banyu Pharma Co Ltd Substituted alkylamine derivatives and pharmaceutical compositions
US6005001A (en) 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
HU219480B (hu) 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
US5461068A (en) * 1993-09-29 1995-10-24 Corwood Laboratories, Inc. Imidazole derivative tincture and method of manufacture
DE4400770C1 (de) * 1994-01-13 1995-02-02 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster zur Abgabe von Estradiol mit mindestens einem Penetrationsverstärker, Verfahren zu seiner Herstellung und seine Verwendung
NZ280065A (en) * 1995-09-20 1998-04-27 Apotex Inc Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives
AU6677698A (en) 1997-03-31 1998-10-22 Johnson & Johnson Consumer Companies, Inc. Solvent system for enhanced penetration of pharmaceutical compounds
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
AU3212099A (en) 1998-03-31 1999-10-18 Johnson & Johnson Consumer Companies, Inc. Method for increasing the permeability of horny human tissue
PT1113785E (pt) * 1998-07-24 2005-08-31 Seo Hong Yoo Solucoes aquosas limpidas de acidos biliares
JP2000053681A (ja) 1998-08-10 2000-02-22 Sankyo Co Ltd 三環性複素環化合物を含有する抗菌剤
DK1222160T3 (da) 1999-10-22 2003-11-17 Richter Gedeon Vegyeszet Fremgangsmåde til fremstilling af substituerede allylaminderivater og salte deraf
GB0014448D0 (en) 2000-06-13 2000-08-09 Novartis Ag Organic compounds
JP4899139B2 (ja) 2000-08-10 2012-03-21 株式会社ポーラファルマ 抗真菌医薬組成物
JP4803511B2 (ja) 2000-08-25 2011-10-26 株式会社ポーラファルマ 抗真菌医薬組成物
JP2002068975A (ja) 2000-08-25 2002-03-08 Pola Chem Ind Inc 抗真菌医薬組成物

Also Published As

Publication number Publication date
WO2002070455A1 (en) 2002-09-12
ATE294154T1 (de) 2005-05-15
JP2004523567A (ja) 2004-08-05
KR20080041756A (ko) 2008-05-13
IL157241A (en) 2009-06-15
US20070088084A1 (en) 2007-04-19
US7488759B2 (en) 2009-02-10
SK9992003A3 (en) 2004-01-08
KR100859609B1 (ko) 2008-09-23
GB0103046D0 (en) 2001-03-21
HUP0303174A2 (hu) 2003-12-29
HK1060876A1 (en) 2004-08-27
AU2002238534C1 (en) 2006-04-13
CN1216034C (zh) 2005-08-24
IL157241A0 (en) 2004-02-19
ZA200306029B (en) 2004-06-28
CZ20032132A3 (cs) 2003-10-15
SI1370513T1 (en) 2005-10-31
ES2240698T3 (es) 2005-10-16
EP1370513A1 (en) 2003-12-17
ECSP034713A (es) 2003-09-24
PL362554A1 (en) 2004-11-02
JP4078206B2 (ja) 2008-04-23
US20040147603A1 (en) 2004-07-29
PT1370513E (pt) 2005-08-31
KR20030077606A (ko) 2003-10-01
RU2003126176A (ru) 2005-03-10
NZ527300A (en) 2005-02-25
AU2002238534B2 (en) 2005-09-29
BR0207077A (pt) 2004-01-20
DE60203890T2 (de) 2006-01-19
PL204812B1 (pl) 2010-02-26
MXPA03007072A (es) 2003-11-18
NO20033473D0 (no) 2003-08-05
CN1491206A (zh) 2004-04-21
NO20033473L (no) 2003-09-17
EP1370513B1 (en) 2005-04-27
DE60203890D1 (de) 2005-06-02
CA2437592A1 (en) 2002-09-12
DK1370513T3 (da) 2005-08-01
RU2289570C2 (ru) 2006-12-20

Similar Documents

Publication Publication Date Title
HUP0301645A3 (en) Hydropyridine derivative acid addition salts, process for their preparation, pharmaceutical compositions containing them and their use
HUP0201646A3 (en) Novel alpha-amino acid derivatives, process for producing them and pharmaceutical compositions containing them
HUP0303347A3 (en) Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis polymorphonucleate and mononucleate cells, process for their preparation and pharmaceutical compositions containing them
HUP0302487A3 (en) New mandelic acid derivatives and their use as throbin inhibitors, process for their preparation and pharmaceutical compositions containing them
HUP0302656A3 (en) Fumaric acid amides, their use for preparation of pharmaceutical compositions and pharmaceutical compositions containing the compounds
HUP0105437A3 (en) Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them
HUP0600141A3 (en) Low hygroscopic aripiprazole-anhydrate process for its preparation, pharmaceutical compositions containing it and its use
HUP0401241A3 (en) Novel cyclohexyl sulphones, process for their preparation and pharmaceutical compositions containing them
HUP0004123A3 (en) Carboxylic acid amide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0500736A3 (en) (s)-2-amino-4-(2-ethanimidoylamino-ethylthio)-butyric acid phosphate salt as nitric oxide synthase inhibitor, process for its preparation and pharmaceutical composition containing it
HUP0300896A3 (en) Beta-amino acid nitrile derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0201088A3 (en) New alpha-amino acid sulphonyl compounds, a process for their preparation and pharmaceutical compositions containing them
HUP0301069A3 (en) Novel biarylcarboxamides, process for their preparation, pharmaceutical compositions containing them and their use
HUP0401619A3 (en) Phenethanolamine derivatives, process for their preparation and pharmaceutical composition containing them
HUP0402264A3 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines process for preparing them, pharmaceutical compositions containing them and use thereof
HUP0303022A3 (en) Quinazoline ditosylate salt compounds, process for their preparation and pharmaceutical compositions containing them
HUP0402225A3 (en) Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them
HUP0301187A3 (en) Novel benzyl-piperidine-derivatives, process for their preparation and pharmaceutical compositions containing them
PL370554A1 (en) New compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
HUP0103063A3 (en) Novel 2h-pyridazin-3-one derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0400040A2 (hu) Szulfonamidok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0202934A3 (en) Arylsulfonamido-substituted hydroxamic acid derivatives, process for their preparation, pharmaceutical compositions containing them and use thereof
HUP0303174A3 (en) Malic acid addition salts of terbinafine, process for their preparation and pharmaceutical compositions containing them
HUP0302912A3 (en) Betha-thio-amino acids, process for their preparation and pharmaceutical compositions containing them
HUP0401082A3 (en) Substituted 4-aminocyclohexanols, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees